Literature DB >> 21916706

Diallyl disulphide, a beneficial component of garlic oil, causes a redistribution of cell-cycle growth phases, induces apoptosis, and enhances butyrate-induced apoptosis in colorectal adenocarcinoma cells (HT-29).

Mohammed O Altonsy1, Simon C Andrews.   

Abstract

Colon cancer is a leading and expanding cause of death worldwide. A major contributory factor to this disease is diet composition; some components are beneficial (e.g, dietary fiber), whereas others are detrimental (e.g., alcohol). Garlic oil is a prominent dietary constituent that prevents the development of colorectal cancer. This effect is believed to be mainly due to diallyl disulphide (DADS), which selectively induces redox stress in cancerous (rather than normal) cells that leads to apoptotic cell death. However, the detailed mechanism by which DADS causes apoptosis remains unclear. We show that DADS treatment of colonic adenocarcinoma cells (HT-29) initiates a cascade of molecular events characteristic of apoptosis. These include a decrease in cellular proliferation, translocation of phosphatidylserine to the plasma-membrane outer-layer, activation of caspase-3 and -9, genomic DNA fragmentation, and G(2)/M phase cell-cycle arrest. Short-chain fatty acids (SCFAs), particularly butyrate (abundantly produced in the gut by bacterial fermentation of dietary polysaccharides), enhance colonic cell integrity but, in contrast, inhibit colonic cancer cell growth. Combining DADS with butyrate augmented the apoptotic effect of butyrate on HT-29 cells. These results suggest that the anticancerous properties of DADS afford greater benefit when supplied with other favorable dietary factors (short chain fatty acids/polysaccharides) that likewise reduce colonic tumor development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21916706     DOI: 10.1080/01635581.2011.601846

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  7 in total

Review 1.  Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Authors:  Jayshree Mishra; Joseph Drummond; Sohel H Quazi; Satya Sridhar Karanki; J J Shaw; Ben Chen; Narendra Kumar
Journal:  Crit Rev Oncol Hematol       Date:  2012-10-23       Impact factor: 6.312

2.  No association between garlic intake and risk of colorectal cancer.

Authors:  Shasha Meng; Xuehong Zhang; Edward L Giovannucci; Jing Ma; Charles S Fuchs; Eunyoung Cho
Journal:  Cancer Epidemiol       Date:  2012-12-21       Impact factor: 2.984

Review 3.  Recent Research Progress on Garlic ( dà suàn) as a Potential Anticarcinogenic Agent Against Major Digestive Cancers.

Authors:  Rajasekaran Raghu; Kuan-Hung Lu; Lee-Yan Sheen
Journal:  J Tradit Complement Med       Date:  2012-07

Review 4.  Autophagy therapeutic potential of garlic in human cancer therapy.

Authors:  Yung-Lin Chu; Rajasekaran Raghu; Kuan-Hung Lu; Chun-Ting Liu; Shu-Hsi Lin; Yi-Syuan Lai; Wei-Cheng Cheng; Shih-Hang Lin; Lee-Yan Sheen
Journal:  J Tradit Complement Med       Date:  2013-07

5.  Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells.

Authors:  Luis Miguel Guamán-Ortiz; Maria Isabel Ramirez Orellana; Edward A Ratovitski
Journal:  Curr Genomics       Date:  2017-04       Impact factor: 2.236

6.  Garlic intake and the risk of colorectal cancer: A meta-analysis.

Authors:  Xi Zhou; Haihua Qian; Dan Zhang; Li Zeng
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

Review 7.  Prevailing Knowledge on the Bioavailability and Biological Activities of Sulphur Compounds from Alliums: A Potential Drug Candidate.

Authors:  Murugan Sesha Subramanian; Giri Nandagopal Ms; Syafinaz Amin Nordin; Karuppiah Thilakavathy; Narcisse Joseph
Journal:  Molecules       Date:  2020-09-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.